Hepatitis Monthly is an international, peer-reviewed clinical journal committed to advancing the field of hepatology through the dissemination of high-quality, evidence-based, and interdisciplinary research. The journal primarily addresses clinicians and researchers, including gastroenterologists, hepatologists, infectious disease specialists, internists, and other healthcare professionals engaged in the management and study of liver diseases.

Established in 2002 by Professor Seyed-Moayed Alavian, Hepatitis Monthly serves as an authoritative platform for the publication of clinically relevant and scientifically robust studies that contribute to the understanding of liver diseases, particularly hepatitis, across diverse populations and healthcare settings.

The journal aims to promote the integration of clinical practice and research by publishing articles that enhance knowledge of disease mechanisms, improve diagnostic and therapeutic approaches, and inform health policy and clinical decision-making in hepatology.

Journal Scope:

Viral hepatitis and related infections
Chronic liver diseases and cirrhosis
Liver fibrosis, liver failure, and associated complications
Non-alcoholic and metabolic-associated fatty liver disease
Hepatocellular carcinoma and other hepatic malignancies
Liver transplantation and post-transplant outcomes
Advances in diagnostic modalities and therapeutic interventions
Molecular and cellular mechanisms of liver diseases
Epidemiology, prevention, and public health aspects of liver diseases
Emerging therapies and clinical innovations of liver diseases

By publishing original investigations, critical syntheses, and evidence-based perspectives, Hepatitis Monthly seeks to facilitate scientific exchange, support clinical excellence, and advance global hepatology.

Official Journal of Research Center for Gastroenterology and Liver Diseases

Crossref